Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results , with sales up 14.6% year on year to $2.62 billion. Its non-GAAP profit of $2.23 per share was 2.1% above ...

It integrates detected objects into detailed context-based quantitative analysis. The software is also an ideal image processing environment for clinicial researchers and dedicated image processors.

Context-based analysis can be done by manually drawing regions of interest. TMA can be analysed and also detected on imported files. Analysis profiles can be created and used for automated analysis.

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024. Overall, Quest had a successful quarter, driven by strategic acquisitions and advancements in its ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Quest Oil Corporation acquires, develops, produces, and explores crude oil and natural gas properties in United States and Canada. The company’s oil and gas lands consist of land in Warner ...